Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitriol for prevention of acute kidney transplant rejection
IRCT20260104068546N1Phase 3Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in kidney allograft rejection comparing Calcitriol arm with Placebo arm (2 arms). Primary endpoints: Incidence of acute rejection, Allograft function and 2 more. Started Jan 2026; status: recruiting.
02
Drugs
calcitriol
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on IRCT20260104068546N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260104068546N1.